Convalescent plasma for administration of passive antibodies against viral agents

Affiliations

¹ Dipartimento di Medicina Clinica e Chirurgia, Centro Hub per le Emocoagulopatie, Napoli, Italy. diminno@unina.it.
² Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
³ Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
⁴ Departmental Medicine Laboratory, ASST Niguarda Hospital, Milan, Italy.
⁵ Max von Pettenkofer Institute, Ludwig Maximilians University of Munich, Munich, Germany.
⁶ Mary Weinfeld Professor of Clinical Research in Hemophilia at the Icahn School of Medicine at Mount Sinai, New York City, NY, USA.

Editorial

Giovanni Di Minno et al. Haematologica. 2020.

. 2020 Dec 1;105(12):2710-2715.

doi: 10.3324/haematol.2020.267427.

¹ Dipartimento di Medicina Clinica e Chirurgia, Centro Hub per le Emocoagulopatie, Napoli, Italy. diminno@unina.it.
² Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
³ Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
⁴ Departmental Medicine Laboratory, ASST Niguarda Hospital, Milan, Italy.
⁵ Max von Pettenkofer Institute, Ludwig Maximilians University of Munich, Munich, Germany.
⁶ Mary Weinfeld Professor of Clinical Research in Hemophilia at the Icahn School of Medicine at Mount Sinai, New York City, NY, USA.

No abstract available

Comment on

Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial.
Perotti C, Baldanti F, Bruno R, Del Fante C, Seminari E, Casari S, Percivalle E, Glingani C, Musella V, Belliato M, Garuti M, Meloni F, Frigato M, Di Sabatino A, Klersy C, De Donno G, Franchini M, Covid-Plasma Task Force. Perotti C, et al. Haematologica. 2020 Dec 1;105(12):2834-2840. doi: 10.3324/haematol.2020.261784. Haematologica. 2020. PMID: 33256382 Free PMC article.

1. Bloch EM, Shoham S, Casadevall A, et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020;130(6):2757-2765. - PMC - PubMed
1. Roback JD, Guarner J. Convalescent plasma to treat COVID-19: possibilities and challenges. JAMA. 2020; 323(16):1561-1562. - PubMed
1. Perotti C, Baldanti F, Bruno R, et al. Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial. Haematologica. 2020;105(12): 2834-2840. - PMC - PubMed
1. Semple JW, Rebetz J, Kapur R. Transfusion-associated circulatory overload and transfusion-related acute lung injury. Blood. 2019;133(17):1840-1853. - PubMed
1. Joyner M, Wright RS, Fairweather D, et al. Early safety indicators of COVID-19 convalescent plasma in 5,000 patients. medRxiv. 2020. May 14. [Epub ahead of print] - PMC - PubMed